Quick Answer
CHEMED CORP reported Cash and Equivalents of $74.52 million for fiscal year 2025.
CHEMED CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $74.52M | -58.2% |
| 2024 | $178.35M | -32.4% |
| 2023 | $263.96M | +256.1% |
| 2022 | $74.13M | +125.3% |
| 2021 | $32.90M | -79.8% |
| 2020 | $162.68M | +2541.7% |
| 2019 | $6.16M | +27.5% |
| 2018 | $4.83M | -56.6% |
| 2017 | $11.12M | -27.4% |
| 2016 | $15.31M | +4.0% |
| 2015 | $14.73M | +4.2% |
| 2014 | $14.13M | -83.3% |
| 2013 | $84.42M | +21.4% |
| 2012 | $69.53M | +82.6% |
| 2011 | $38.08M | -23.7% |
| 2010 | $49.92M | -55.6% |
| 2009 | $112.42M | +2998.6% |
| 2008 | $3.63M | -27.3% |
| 2007 | $4.99M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $129.75M | -45.6% | -48.1% |
| June 30, 2025 | $249.90M | +12.1% | +43.7% |
| March 31, 2025 | $173.88M | -44.5% | -2.5% |
| December 31, 2024 | $178.35M | -32.4% | -25.2% |
| September 30, 2024 | $238.45M | +37.7% | +7.0% |
| June 30, 2024 | $222.90M | +39.4% | -28.9% |
| March 31, 2024 | $313.35M | +439.8% | +18.7% |
| December 31, 2023 | $263.96M | +256.1% | +52.4% |
- CHEMED CORP showed a decrease of -58.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, CHEMED CORP’s cash and equivalents has grown by 1393.9% (from $4.99 million to $74.52 million).
- The most recent figure is from CHEMED CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: